ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Internal Medicine

Top Internal Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ROBERT KELLER MD

Internal Medicine

19,937

$1.17M

820
585 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

29%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$59
Average prescription price

Avg: $67

JAIME HERNANDEZ MD

Internal Medicine

19,332

$1.3M

819
667 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$67
Average prescription price

Avg: $67

JACQUELINE CARRUTHERS M.D.

Internal Medicine

24,550

$1.78M

819
540 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 27%

$73
Average prescription price

Avg: $67

PETER NUTSON MD

Internal Medicine

14,896

$724K

816
576 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$49
Average prescription price

Avg: $67

JULIO OLIVIERI M.D.

Internal Medicine

14,632

$771K

815
452 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

33%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $67

DANIEL SMITH M.D.

Internal Medicine

10,303

$738K

814
595 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$72
Average prescription price

Avg: $67

ROBERT RAMIREZ M.D,

Internal Medicine

17,593

$1.19M

813
564 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$67
Average prescription price

Avg: $67

RAYMOND ACEBO MD

Internal Medicine

18,686

$1.13M

813
563 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $67

THOMAS DANIEL M.D.

Internal Medicine

14,187

$963K

812
496 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$68
Average prescription price

Avg: $67

OMAR GOMEZ MD

Internal Medicine

16,421

$1.3M

810
644 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$79
Average prescription price

Avg: $67

MARK BLICK D.O.

Internal Medicine

16,149

$1.18M

809
676 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

19%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$73
Average prescription price

Avg: $67

HUGO ROJAS MD, PA

Internal Medicine

16,362

$1.17M

805
318 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

36%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$71
Average prescription price

Avg: $67

RICHARD LOCK M.D.

Internal Medicine

20,654

$1.08M

803
657 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$52
Average prescription price

Avg: $67

MANUEL MERCADO MD

Internal Medicine

18,496

$1.94M

801
655 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 27%

$105
Average prescription price

Avg: $67

VINCENT GONZABA MD

Internal Medicine

8,177

$581K

801
525 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$71
Average prescription price

Avg: $67

ANGELES LAI ZAYAS M.D.

Internal Medicine

16,376

$960K

801
678 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$59
Average prescription price

Avg: $67

MICHAEL ROMAIN MD

Internal Medicine

31,839

$1.93M

800
710 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $67

PAUL SILVA M.D.

Internal Medicine

8,208

$431K

799
690 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $67

WILLIAM GEORGE M.D.

Internal Medicine

34,277

$2.04M

795
681 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$59
Average prescription price

Avg: $67

E. HUDMAN M.D.

Internal Medicine

19,863

$1.3M

793
582 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$65
Average prescription price

Avg: $67

LISA DAVIS M.D.

Internal Medicine

19,036

$1.31M

793
591 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $67

YURI CABALLERO MD

Internal Medicine

16,943

$848K

792
636 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 15%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$50
Average prescription price

Avg: $67

ZHIHAO DAI M.D.

Internal Medicine

12,597

$569K

790
601 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$45
Average prescription price

Avg: $67

CHARITY ABREU-LAWRENCE M.D.

Internal Medicine

21,404

$1.7M

788
670 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 27%

$79
Average prescription price

Avg: $67

NILESH MEHTA M.D.

Internal Medicine

11,760

$991K

786
640 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$84
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank